We provide you with 20 years of free, institutional-grade data for KURA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KURA. Explore the full financial landscape of KURA stock.
Total insider purchase within 3 month on this page: $702,670
Total insider selling within 3 month on this page: -$698,010
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Powl Brian T. | Sale | -8,891 | $8.94 | $79,505 | 2025-09-29 |
| Powl Brian T. | Grant, award...etc | 48,900 | 2025-09-29 | ||
| Bair Teresa Brophy | Sale | -8,805 | $8.94 | $78,736 | 2025-09-29 |
| Bair Teresa Brophy | Grant, award...etc | 48,900 | 2025-09-29 | ||
| WILSON TROY EDWARD | Sale | -36,615 | $8.94 | $327,419 | 2025-09-29 |
| WILSON TROY EDWARD | Grant, award...etc | 182,500 | 2025-09-29 | ||
| FORD KATHLEEN | Sale | -6,892 | $8.94 | $61,630 | 2025-09-29 |
| FORD KATHLEEN | Grant, award...etc | -48,900 | 2025-09-29 | ||
| Leoni Mollie | Sale | -12,314 | $8.94 | $110,114 | 2025-09-29 |
| Leoni Mollie | Grant, award...etc | 82,500 | 2025-09-29 | ||
| DOYLE THOMAS JAMES | Sale | -4,541 | $8.94 | $40,607 | 2025-09-29 |
| DOYLE THOMAS JAMES | Grant, award...etc | 24,966 | 2025-09-29 | ||
| WILSON TROY EDWARD | Open Market Purchase | 50,000 | $8.2 | 2025-09-09 | |
| WILSON TROY EDWARD | Open Market Purchase | 50,000 | $5.85 | 2025-08-14 | |
| VASCONCELLES MICHAEL | Grant, award...etc | 28,500 | 2025-06-06 | ||
| Szela Mary T | Grant, award...etc | 28,500 | 2025-06-06 | ||
| Hasnain Faheem | Grant, award...etc | 28,500 | 2025-06-06 | ||
| Malley Thomas | Grant, award...etc | 28,500 | 2025-06-06 | ||
| SCHAFER CAROL | Grant, award...etc | 28,500 | 2025-06-06 | ||
| Parks Diane L. | Grant, award...etc | 28,500 | 2025-06-06 | ||
| Collins Helen Louise | Grant, award...etc | 28,500 | 2025-06-06 | ||
| Bair Teresa Brophy | Sale | -1,559 | $5.96 | $9,292 | 2025-05-19 |
| FORD KATHLEEN | Sale | -1,558 | $6.28 | $9,777 | 2025-05-19 |
| Hasnain Faheem | Sale | -22,682 | $8 | $181,456 | 2025-03-24 |
| Hasnain Faheem | Derivatives Exercise | 22,682 | 2025-03-24 | ||
| Burrows Francis | Sale | -2,166 | $7.87 | $17,051 | 2025-01-28 |
| Powl Brian T. | Sale | -1,583 | $7.87 | $12,461 | 2025-01-28 |
| DOYLE THOMAS JAMES | Sale | -4,949 | $7.87 | $38,958 | 2025-01-28 |
| FORD KATHLEEN | Sale | -1,817 | $7.87 | $14,303 | 2025-01-28 |
| Leoni Mollie | Sale | -4,963 | $7.87 | $39,068 | 2025-01-28 |
| Bair Teresa Brophy | Sale | -7,281 | $7.87 | $57,315 | 2025-01-28 |
| Burrows Francis | Initial | 2025-01-07 | |||
| Leoni Mollie | Initial | 2025-01-07 | |||
| Burrows Francis | Grant, award...etc | 185,000 | 2025-01-07 | ||
| Leoni Mollie | Grant, award...etc | 138,750 | 2025-01-07 | ||
| DOYLE THOMAS JAMES | Grant, award...etc | 85,000 | 2025-01-06 | ||
| Bair Teresa Brophy | Grant, award...etc | 138,750 | 2025-01-06 | ||
| Powl Brian T. | Grant, award...etc | 138,750 | 2025-01-06 | ||
| WILSON TROY EDWARD | Grant, award...etc | 625,000 | 2025-01-06 | ||
| FORD KATHLEEN | Grant, award...etc | 185,000 | 2025-01-06 | ||
| FORD KATHLEEN | Sale | -526 | $16.03 | $8,434 | 2024-11-19 |
| VASCONCELLES MICHAEL | Grant, award...etc | 69,333 | 2024-09-17 | ||
| Malley Thomas | Grant, award...etc | 26,000 | 2024-06-07 | ||
| Collins Helen Louise | Grant, award...etc | 26,000 | 2024-06-07 | ||
| Hasnain Faheem | Grant, award...etc | 26,000 | 2024-06-07 | ||
| Parks Diane L. | Grant, award...etc | 26,000 | 2024-06-07 | ||
| Szela Mary T | Grant, award...etc | 26,000 | 2024-06-07 | ||
| SCHAFER CAROL | Grant, award...etc | 26,000 | 2024-06-07 | ||
| Bair Teresa Brophy | Sale | -2,615 | $22.15 | $57,916 | 2024-05-20 |
| DALE STEPHEN | Sale | -11,983 | $17.8 | $213,303 | 2024-01-31 |
| Bair Teresa Brophy | Sale | -2,053 | $17.8 | $36,544 | 2024-01-31 |
| DOYLE THOMAS JAMES | Sale | -2,318 | $17.8 | $41,262 | 2024-01-31 |
| FORD KATHLEEN | Sale | -1,496 | $17.8 | $26,630 | 2024-01-31 |
| WILSON TROY EDWARD | Sale | -91,052 | $20.23 | $1,841,982 | 2024-01-26 |
| WILSON TROY EDWARD | Derivatives Exercise | 91,052 | 2024-01-26 | ||
| DALE STEPHEN | Grant, award...etc | 185,000 | 2024-01-04 | ||
| WILSON TROY EDWARD | Grant, award...etc | 560,000 | 2024-01-04 | ||
| Bair Teresa Brophy | Grant, award...etc | 138,750 | 2024-01-04 | ||
| DOYLE THOMAS JAMES | Grant, award...etc | 63,750 | 2024-01-04 | ||
| FORD KATHLEEN | Grant, award...etc | 185,000 | 2024-01-04 | ||
| Powl Brian T. | Grant, award...etc | 45,000 | 2024-01-04 | ||
| Powl Brian T. | Grant, award...etc | 200,000 | 2023-08-16 | ||
| Malley Thomas | Open Market Purchase | 50,000 | $11.5 | 2023-06-21 | |
| Collins Helen Louise | Grant, award...etc | 26,000 | 2023-06-02 | ||
| Malley Thomas | Grant, award...etc | 26,000 | 2023-06-02 | ||
| Hasnain Faheem | Grant, award...etc | 26,000 | 2023-06-02 | ||
| Szela Mary T | Grant, award...etc | 26,000 | 2023-06-02 | ||
| SCHAFER CAROL | Grant, award...etc | 26,000 | 2023-06-02 | ||
| Parks Diane L. | Grant, award...etc | 26,000 | 2023-06-02 | ||
| WILSON TROY EDWARD | Grant, award...etc | 560,000 | 2023-02-21 | ||
| DOYLE THOMAS JAMES | Grant, award...etc | 74,375 | 2023-02-21 | ||
| FORD KATHLEEN | Grant, award...etc | 185,000 | 2023-02-21 | ||
| DALE STEPHEN | Grant, award...etc | 208,125 | 2023-02-21 | ||
| Bair Teresa Brophy | Grant, award...etc | 161,875 | 2023-02-21 | ||
| FLOWERS KIRSTEN | Sale | -1,906 | $13.89 | $26,474 | 2023-01-31 |
| FORD KATHLEEN | Sale | -1,821 | $13.89 | $25,294 | 2023-01-31 |
| DOYLE THOMAS JAMES | Sale | -1,548 | $13.89 | $21,501 | 2023-01-31 |
| DALE STEPHEN | Sale | -9,225 | $13.89 | $128,138 | 2023-01-31 |
The information provided in this report about KURA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kura Oncology, Inc(NASDAQ:KURA) 
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidates are tipifarnib, an orally bioavailable inhibitor ...
Website: http://www.kuraoncology.com
Founded: 2014
Full Time Employees: 83
CEO / Co-Founder: Troy Wilson
Sector: Healthcare
Industry: Biotechnology